GCM
Graham Capital Management Portfolio holdings
AUM
$3.28B
1-Year Return
7.17%
This Quarter Return
-1.48%
1 Year Return
+7.17%
3 Year Return
+21.95%
5 Year Return
+42.01%
10 Year Return
+61.8%
AUM
$3.34B
AUM Growth
+$417M
(+14%)
Cap. Flow
-$930M
Cap. Flow
% of AUM
-27.87%
Top 10 Holdings %
Top 10 Hldgs %
32.11%
Holding
1,369
New
436
Increased
247
Reduced
256
Closed
389
Top Buys
| 1 |
Walmart
WMT
|
+$41.8M |
| 2 |
Broadcom
AVGO
|
+$32.4M |
| 3 |
Meta Platforms (Facebook)
META
|
+$31.3M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$31.3M |
| 5 |
Mastercard
MA
|
+$29.7M |
Top Sells
| 1 |
Coca-Cola
KO
|
+$25.7M |
| 2 |
Johnson & Johnson
JNJ
|
+$18M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$16.2M |
| 4 |
IBM
IBM
|
+$15.9M |
| 5 |
Boeing
BA
|
+$14.7M |
Sector Composition
| 1 | Technology | 10.3% |
| 2 | Consumer Discretionary | 9.75% |
| 3 | Financials | 8.76% |
| 4 | Industrials | 7.82% |
| 5 | Communication Services | 5.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Cerus
CERS
$226M
| $87.6K | ﹤0.01% |
54,057
+41,805
| +341% | +$67.7K |
|
902
MacroGenics
MGNX
$109M
| $85.4K | ﹤0.01% |
18,332
-3,095
| -14% | -$14.4K |
|
903
Vimeo
VMEO
$1.28B
| $81.8K | ﹤0.01% |
+23,102
| New | +$81.8K |
|
904
Sana Biotechnology
SANA
$739M
| $76.9K | ﹤0.01% |
+19,861
| New | +$76.9K |
|
905
Avidity Biosciences
RNA
$5.97B
| $76.5K | ﹤0.01% |
11,993
-7,084
| -37% | -$45.2K |
|
906
Nu Holdings
NU
$74.9B
| $75K | ﹤0.01% |
+10,343
| New | +$75K |
|
907
E.W. Scripps
SSP
$246M
| $73.8K | ﹤0.01% |
13,459
-11,730
| -47% | -$64.3K |
|
908
ThredUp
TDUP
$1.33B
| $73.4K | ﹤0.01% |
+18,310
| New | +$73.4K |
|
|
CIO
909
City Office REIT
CIO
$280M
| $70.2K | ﹤0.01% |
+16,507
| New | +$70.2K |
|
|
STKL
910
SunOpta
STKL
$735M
| $69.7K | ﹤0.01% |
20,689
+971
| +5% | +$3.27K |
|
911
Douglas Elliman
DOUG
$230M
| $69K | ﹤0.01% |
30,534
-42,946
| -58% | -$97.1K |
|
912
Marqeta
MQ
$2.64B
| $68.9K | ﹤0.01% |
+11,526
| New | +$68.9K |
|
913
Conduent
CNDT
$442M
| $68.5K | ﹤0.01% |
19,684
-24,533
| -55% | -$85.4K |
|
914
Aldeyra Therapeutics
ALDX
$333M
| $67.6K | ﹤0.01% |
+10,123
| New | +$67.6K |
|
915
Perimeter Solutions
PRM
$3.22B
| $63.2K | ﹤0.01% |
+13,921
| New | +$63.2K |
|
916
Origin Materials
ORGN
$80.2M
| $63.2K | ﹤0.01% |
49,375
+34,057
| +222% | +$43.6K |
|
917
Rekor Systems
REKR
$140M
| $63.2K | ﹤0.01% |
+22,406
| New | +$63.2K |
|
918
Hyliion Holdings
HYLN
$288M
| $62.9K | ﹤0.01% |
53,303
-11,037
| -17% | -$13K |
|
919
Erasca
ERAS
$440M
| $61.5K | ﹤0.01% |
31,229
-27,692
| -47% | -$54.6K |
|
920
Olo Inc
OLO
$1.74B
| $60.8K | ﹤0.01% |
+10,029
| New | +$60.8K |
|
921
Hanesbrands
HBI
$2.21B
| $60.7K | ﹤0.01% |
15,338
-258,078
| -94% | -$1.02M |
|
922
Mersana Therapeutics
MRSN
$36.7M
| $59.5K | ﹤0.01% |
1,873
-1,077
| -37% | -$34.2K |
|
923
Sangamo Therapeutics
SGMO
$160M
| $57.6K | ﹤0.01% |
96,102
+28,354
| +42% | +$17K |
|
|
GPMT
924
Granite Point Mortgage Trust
GPMT
$142M
| $56.7K | ﹤0.01% |
11,628
-13,744
| -54% | -$67.1K |
|
925
Fulcrum Therapeutics
FULC
$378M
| $52.6K | ﹤0.01% |
11,845
-20,103
| -63% | -$89.3K |
|